Kentucky Biotech News (United States)

Peptides International announces new management structure, including new President and Chief Operating officers, and Vice President, following very successful year and expanded opportunities, especially in custom peptide synthesis.

Advanced Cancer Therapeutics CEO to Present Preclinical Data on Cancer Metabolism Drug at MidAmerica Healthcare Venture Forum

Peptides International in partnership with Baylor University secures highly sought-after NIH RO1 grant

Peptides International announces publication of peer-reviewed scientific paper outlining possible applications of peptide toxins for drug discovery relating to autoimmune diseases.

BearCreekResearch introduces the extraordinary Life - On Purpose Wellness Program at the March 30 Hilton Garden Inn presentation at 7pm. The Ancient techniques are as valid today as yesterday! The formula may astound you at the power and simplicity!

STOP SMOKING IN LESS 1Hr. Possible? DonHall/BearCreekResearch says YES! ... Reprogramming your DNA through Ancient Secret Code Builds Happy Successful Lives!

Peptides International Inc. is pleased to announce its newest product offering, Maleimide Activated Keyhole Limpet Hemocyanin (mKLH). It is a popular choice to use as a carrier protein for haptens to assist in the activation of an immune response.

Peptides International Inc. announced today the addition of Dr. Michael Pennington to the company’s executive team, effective December 1st.

The National Heart, Lung and Blood Institute and KY Cabinet for Economic Development Combine for $299,683 in Awards to Lexington, KY-based Company

Peptides International, Inc. and Axxora, LLC, entered into an agreement that allows for Axxora.com to serve as distributor of Peptides International’s products within the regions of Europe, Latin America, Australia, and New Zealand.

Peptides International Announces Free Book Giveaway! Shipping is free for those ordering in the continental US! Titles include many proceedings of peptide conference meetings.

Vindico receives a highly competitive grant from the Gates Foundation in the fourth funding round of Grand Challenges Explorations, an initiative to help scientists around the world explore bold ways to improve health in developing countries.

In recognition of rapidly growing applications in a variety of research and drug development areas, Peptides International, Inc. has announced the launch of a comprehensive RGD TECHNOLOGY PLATFORM.

National Cancer Institute and KY Cabinet for Economic Development Combine for $412,628 in Awards to Lexington, KY - based Transposagen Biopharmaceuticals, Inc.

Transposagen Biopharmaceuticals, Inc. has announced that it is the recipient of over $395,000 in additional Small Business Innovation Research (SBIR) funding from the National Institutes of Health and the KY Cabinet for Economic Development.

Trans Genic, Inc. Gains Non-Exclusive Marketing Rights

SRD’s emphasis on and experience within Puerto Rico’s regulatory environment allows its clients to operate efficiently and effectively

Lexington, KY biotech firm approved for up to $325,000 in the form of a forgivable loan from the Kentucky High-Tech Investment Pool

Dr. Haig H. Kazazian, Jr. Recognized for His Career Achievement in Human Genetics Research

Researchers have Access to Disease Models for the First Time

KORC Website Directed Toward Academic and Pharmaceutical Researchers

Dr. Blair Madison Receives Ruth L. Kirschstein National Research Service Award

Dr. Eric Ostertag Receives Best Abstract Award

Transposagen Biopharmaceuticals, Inc. Leaving Philadelphia for the Bluegrass State

Knockout Rat Data Base Now On Line At Knock Out Rat Consortium Website